Update your tester profile Login
  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies.

    If you have registered with Prism in the past, please call Dayna 651-724-5047 to update your profile or learn about available studies. 

    We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

     

    Unfortunately at this time, Prism can not allow volunteers who live over 200 miles away to participate in research studies. If you live out of state or over 200 miles away please call Geoff at 651-641-2911 with questions. 

  • Refer Your Friends & Family to Participate

    Simply help us get the word out about Prism Clinical Research and we’ll give you $100 for every friend you refer that completes a study.

    It’s that easy! Make money with each referral, and there’s no limit to how many friends you can refer!

    Rules:

    • Subject must complete the study.
    • Subject may not be referred more than one time.
    • Subjects may not refer each other.
    • Subject must complete the study before payment can be received.
    • Subjects eligible for Referral: (1) Must not be in Prism Clinical Research database; (2) Must not have participated in any study at Prism.
    • In the event that a subject is referred by multiple people, the first person who referred will receive payment.
    • Eligibility will be determined by Prism. Prism reserves the right to revise or eliminate this program at any time without notice.

     

     

  • Diagnosed with Liver Impairment?

    Prism Research has upcoming studies for individuals diagnosed with liver impairment.  These studies will help determine how an investigational drug is broken down and removed from the body in volunteers with various degrees of liver impairment when compared to volunteers with normal liver function.

     If you or someone you know has been diagnosed with liver impairment and are interested in being considered for these studies, please contact Dayna at 651-724-5047 or register with our database and we will call you. Financial compensation for study participation ranges from $400-$3500.

    Currently, we do not have any studies available for those diagnosed with liver impairment. We hope to start a study in the near future. 

    Contact Dayna 651-724-5047 or daynas@prismresearchinc.com

  • **Freelancers Wanted**

    Freelancers, participate in a research study at Prism Research and earn extra income while completing your freelance projects in our comfortable facility by participating in one of our many research studies. If you're 18 - 60, healthy and have a flexible schedule, Prism Research has several current and upcoming FDA Approved Studies for you to consider. 

    Participants will receive health examinations and blood tests at no charge, meals and compensation ranging from $900 to $3,500 (or more) for study participation time. 

    Call for more information if you:
    � Currently Live in Minnesota or Western Wisconsin
    � Have Flexibility To Work Remotely
    � Want to Earn Extra Income

    *Interested in learning more about what clinical research studies are available? Reply or call Lindsay, Recruitment Coordinator at (651) 368-3360.

    Located in St. Paul

  • Study 1710 Part 1: Individuals with Moderate Renal Impairment

    Research Purpose: To determine whether the investigational drug displays the clinical safety profile to support further development in patients with moderately impaired renal function.

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women of non-childbearing potential are allowed to participate

    Age

    40-85 years of age

    Body Mass Index (BMI)

    Between 18-40 kg/m²

    Minimum Weight

    50 kg

    MDRD

    30-59 mL/min/1.73 m²

    Angiotensin receptor blocker (ARB)

    Must be on an ARB for at last a month prior to screening

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 11 weeks. 

    Clinic Stay

    • Participants will be confined at Prism Clinical Research one time during the study period for up to 16 days and (15 nights).

    Return Clinic Visits

    • There is one return clinic visit approximately 1 week after discharge.

     

    Phone Call

    • There is one Phone call approximately 30 days after your final return visit.

     

    Screenings begin: July 19th 2017

    Anticipated start date for Study 1710:  25 July 2017            

     

    Compensation for participation time: Up to $3725.00 if all clinic visits are completed.

                           

    For information regarding this study contact Kevin @: 651-724-5046 or kfitzgerald@prismresearchinc.com

     

  • Study 1708: Male and Female Participants with Migraine

    Research Purpose: Study 1708 is designed to evaluate the cognitive effects in participants receiving topiramate for prophylactic treatment of migraine comparing immediate release versus extended release formulations. Participants will receive dosings of both FDA approved formulations of topiramate.

     The following will be evaluated:

    • The effect of multiple doses of topiramate (immediate release and extended release) on cognition in participants with migraine.

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women who are not pregnant, considering becoming pregnant, breast feeding or lactating are allowed to participate.  Women using acceptable forms of birth control are allowed to participate.

    Age

    18-65 years

    Body Mass Index (BMI)

    There is no body mass index requirement for this study.

    Weight

    There is no weight requirement for this study.

    Drug Testing

    Must test negative for drugs of abuse. 

    Health History

    History of episodic migraine with or without aura for at least 6 months prior to the screening visit and a frequency of 3 or more headache attacks per month during the past 3 months.

    Right hand dominant.

    On a stable dose for 3 months of a selective serotonin reuptake inhibitor for depression and/or anxiety.

    Special Requirements

    • Must be able and willing to take oral doses of the study medication at home.
    • Must have a working phone number during the entire study.

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 8 weeks.

    Inpatient Stay

    • Participants will admit to Prism Clinical Research 3 times
    • The inpatient stay is approximately 1 day one time (1 overnight) and 2 days two times  (2 overnights)

    Outpatient Visits

    • There are 3 outpatient visits during the study.
    • The outpatient visits are approximately 2 hours long. 

     

    Compensation for participation time:   Up to $­­­­­­­­­­­­­­1,660.00

    First screen: 8/28

    First Admit; 9/11

    For information regarding this study contact Kevin at 651-724-5046

  • Study 1714: Healthy Males and Females

    Study 1714 Healthy Female and Male Participants

     

    Research Purpose: To evaluate how one drug interacts with an investigational drug being developed for the treatment of high cholesterol.

     

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate.

    Females

    Women who are not breastfeeding, are not pregnant or planning to become pregnant are allowed to participate.  Women using an acceptable method of birth control are allowed to participate.

    Age

    18-60 years of age

    Weight/Body Mass Index (BMI)

    Minimum weight of 50 kg/110 lbs.

    BMI between 18-35 kg/m²

    Tobacco/Nicotine Use

    Subject must be a non-smoker and must have not used tobacco/nicotine containing products including electronic cigarettes within 3 months prior to entering the study.  No tobacco/nicotine use is permitted for the duration of the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor.

    Medications

    No use of any prescription or nonprescription drugs, vitamins, herbal remedies, or dietary supplements within 14 days of entering the study.

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 7 weeks.

    Clinic Stay

    • Participants will admit to Prism Clinical Research 2 times.
    • The first in clinic stay will last approximately 4 days (3 overnights).
    • The second in clinic stay will last approximately 4 days (3 overnights).

    Return Clinic Visits

    • There are 12 morning return clinic visits.

     

    Compensation for participation time: Up to $2520.00

     

    For information regarding this study contact Lindsay at: 651-368-3360 lindsayd@prismresearchinc.com or Dayna 651-724-5047 or daynas@prismresearchinc.com

     

  • Study 1718 Healthy Female and Male Participants

    Research Purpose: To evaluate how one drug interacts with an investigational drug being developed for the treatment of certain types of cancers.

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate and must use acceptable birth control.

    Females

    Women who are not breastfeeding, are not pregnant or planning to become pregnant are allowed to participate.  Women using an acceptable method of birth control are allowed to participate.

    Age

    18-55 years of age

    Weight/Body Mass Index (BMI)

    BMI between 18-30 kg/m²

    Tobacco/Nicotine Use

    Subjects must not have used tobacco or tobacco containing products, more frequently than 5 cigarettes per week within 2 months prior to screening or anytime within the week before screening and throughout the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor.

    Medications

    No use of any prescription or nonprescription drugs, vitamins, herbal remedies, or dietary supplements within at least 14 days of entering the study.

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 7-9 weeks.

    Cohort 1

    Clinic Stay

    • Participants will admit to Prism Clinical Research 2 times.
    • The first in clinic stay will last approximately 3 days (2 overnights).
    • The second in clinic stay will last approximately 11 days (10 overnights).

    Return Clinic Visits

    • There are 7 morning return clinic visits.

    Cohort 2

    Clinic Stay

    • Participants will admit to Prism Clinical Research 1 time.
    • The in clinic stay will last approximately 9 days (8 overnights).

    Return Clinic Visits

    • There is 1 morning return clinic visit.

    Compensation for participation time:

    Cohort 1 Up to $3675.00

    Cohort 2 Up to $ 2150.00

    For information regarding this study contact Lindsay at: 651-368-3360 lindsayd@prismresearchinc.com or Dayna 651-724-5047 or daynas@prismresearchinc.com

  • Upcoming Studies

     

     

     Prism has a variety of upcoming studies to participate in: 

    • 1711: Vaccine Study (November 2017)
    • 1719: Hepatic Study
    • 1620 Part 3: Volunteers with Atopic Dermatitis
    • Studies for volunteers with Overactive Bladder
    • Studies for healthy males and females

     

    To be put on the call list and receive more information, when available, please contact Dayna at daynas@prismresearchinc.com or Lindsay at lindsayd@prismresearchinc.com.

The Enrollment Process

Most people who are interested in volunteering for a clinical trial have many questions. This page is designed to answer the most common questions our recruitment team receives from volunteers. Please do not hesitate to contact a recruiter by phone or email if you would like additional information or have a question that is not addressed on this page. We want to ensure that you are well informed before you agree to volunteer for a trial and we are happy to answer any questions you might have.


Icon 35    Step 1: Phone Interview

Arrange a phone interview and one of our recruiters will determine if you are an eligible candidate. The Phone Screen is a conversation between you, as a potential volunteer, and a recruiter. It is the first required step in participating in a clinical trial. and you should set aside about 45 minutes to an hour. Your recruiter will ask you a series of general questions concerning your contact information, height and weight, age, race and personal health history. By collecting this information, your recruiter will determine if you might fit the criteria for any upcoming studies. Many of the phone screen questions can be answered online.  Doing so will notify our recruitment team that you are interested in studies, will register you for study updates and will also speed up the phone screen process. Once you complete your online portion, a recruiter will call you to complete the phone screen.

Once your information has been added into the database, either by you via download or by speaking with a recruiter, your recruiter will then discuss the details of any studies you might qualify for. The recruiter will explain the time commitment, specific dates, research purpose and compensation of the trials.

If you are interested in participating in a suggested trial, your recruiter must then make certain that you are not disqualified from that trial due to any exclusion criteria. You will be asked another series of questions that specifically relate to the study you are volunteering for. The exclusion criteria are established by the study sponsor in order to ensure the safety of volunteers and the accuracy of data collected.

Icon 13    Step 2: Informed Consent

Signing Informed Consent and undergoing your Physical Screen will happen during the same visit to our facility. Expect the visit to take approximately 2.5 hours. Volunteers are required to provide a photo ID at the time of the Physical Screen. If their photo ID does not list a current address, volunteers must provide additional documentation of their address such as a utility or cable bill. It is mandatory that all potential volunteers review the Informed Consent Form. This is regarded as the most important process in clinical trials. The Informed Consent Form is a document that details all aspects of the research study, the potential risks involved and what happens during the entire study. It is approved by an ethics and safety committee called the Institutional/Independent Review Board (IRB). No studyrelated procedures or requirements can begin until volunteers understand and sign the specific, studyrelated Informed Consent Form. 

Volunteers receive a copy of the Informed Consent Form. You will be required to sign the Informed Consent Form if you are interested in continuing the enrollment process. The Informed Consent Form does not legally obligate you to participate in the trial. It also does not guarantee you a position in the trial. It is a document designed to protect your rights as a volunteer; it confirms you have been given information concerning all aspects of the trial and that you understand what will take place during the trial.

We are committed to a transparent, trusting and open relationship with our volunteers. 

Icon 51    Step 3: Physical Screen

Each trial requires a different series of procedures as part of the Physical Screen. Common procedures include: blood draws, heart monitoring, vital signs, body measurements, urine samples, and drug tests.

You will meet with a doctor or Physician Assistant at the time of your Physical Screen. He or she will perform a brief physical examination and discuss your personal health history. Volunteers are strongly encouraged to ask him/her any questions you might have concerning the study. 

All trials require a minimum of one Physical Screen, however; some studies require multiple screening appointments. Some studies also require hearing or eye exams which take place at clinics working in conjunction with Prism. Your recruiter will outline the screening schedule at the time of your Phone Screen.

Once all of your lab work has been completed and reviewed, a Prism staff member will call to notify you of your enrollment status. If your lab results meet the requirements for the study, the staff member will confirm your enrollment and give you admit instructions.

Icon 40    Step 4: Your Study

Once your study has been scheduled, you can make preparations for your visit. Each study is different – some require a series of visits and keeping a home diary, some require you to remain at the clinic for several hours or days, depending on the drug and the effects being studied. You will have a clear and complete understanding of your study before you arrive. You will be informed about what to bring with you, where to report, and what will be necessary for a successful trial.

Our first priority is that you understand and are comfortable with our process every step of the way

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel